findmyKOL
Clinical trialNCT01211145CompletedPhase 4Interventional

Zomig - Treatment of Acute Migraine Headache in Adolescents

SponsorAstraZenecaEnrollment1,653Migraine Headache
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to investigate if Zomig® Nasal Spray will help children (age 12-17 years) with migraine headaches feel better. This will be done by comparing 3 different doses of Zomig Nasal Spray with placebo nasal spray (inactive treatment).
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

74 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Estonia
  • Research Site

    Tallinn, Estonia

  • Research Site

    Tartu, Estonia

Finland
  • Research Site

    Helsinki, Finland

  • Research Site

    Mikkeli, Finland

  • Research Site

    Turku, Finland

Hungary
  • Research Site

    Budapest, Hungary

  • Research Site

    Debrecen, Hungary

  • Research Site

    Gyula, Hungary

  • Research Site

    Miskolc, Hungary

  • Research Site

    Nagykanizsa, Hungary

  • Research Site

    Nyíregyháza, Hungary

  • Research Site

    Pécs, Hungary

  • Research Site

    Sopron, Hungary

  • Research Site

    Szekszárd, Hungary

Latvia
  • Research Site

    Riga, Latvia

  • Research Site

    Valmiera, Latvia

Poland
  • Research Site

    Bialystok, Poland

  • Research Site

    Bydgoszcz, Poland

  • Research Site

    Elblag, Poland

  • Research Site

    Gdansk, Poland

  • Research Site

    Kielce, Poland

  • Research Site

    Olsztyn, Poland

  • Research Site

    Poznan, Poland

Serbia
  • Research Site

    Belgrade, Serbia

  • Research Site

    Novi Sad, Serbia

Slovakia
  • Research Site

    Dolný Kubín, Slovakia

  • Research Site

    Nitra, Slovakia

  • Research Site

    Zvolen, Slovakia

United States
  • Research Site

    Phoenix, Arizona, United States

  • Research Site

    Fresno, California, United States

  • Research Site

    Fullerton, California, United States

  • Research Site

    Newport Beach, California, United States

  • Research Site

    Sacramento, California, United States

  • Research Site

    San Diego, California, United States

  • Research Site

    San Francisco, California, United States

  • Research Site

    Centennial, Colorado, United States

  • Research Site

    Colorado Springs, Colorado, United States

  • Research Site

    Thornton, Colorado, United States

  • Research Site

    Fairfield, Connecticut, United States

  • Research Site

    Boca Raton, Florida, United States

34 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

PlaceboZolmitriptan →
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Sept 2010
Primary completion
31 Oct 2013
Completion
31 Oct 2013
Last update posted
18 May 2016
Registered enrollment
1,653
Registry id
NCT01211145
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.